Release Date: 01/07/14 16:36 Summary: UNMARKEATBLE PARCELS Price Sensitive: No Download Document 849.96KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%